ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

21 links0 made here, not in the record20 judgments1 judge (the rules as one: Rule based)8 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06317662Testing the Addition of theAnti-cancer Drug Venetoclaxand/or the Anti-cancerImmunotherapy Blinatumomabto the Usual ChemotherapyTreatment for Infants WithNewly DiagnosedNational Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 25 · ClinicalTrials.gov record · Version of 2026-09-25Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Oct 27 · ClinicalTrials.gov record · Version of 2026-10-27Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSLeukemia, Biphenotypic, Acu…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionBurkitt LymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAsparaginase erwinia chrysa…Intervention entry›As of now · Rule based · BackgroundBackgroundBlinatumomabIntervention entry›As of now · Rule based · TestedTestedCalaspargase pegolIntervention entry›As of now · Rule based · BackgroundBackgroundCyclophosphamideIntervention entry›As of now · Rule based · BackgroundBackgroundCytarabineIntervention entry›As of now · Rule based · BackgroundBackgroundDaunorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundDexamethasoneIntervention entry›As of now · Rule based · BackgroundBackgroundDoxorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundLeucovorinIntervention entry›As of now · Rule based · BackgroundBackgroundLevoleucovorinIntervention entry›As of now · Rule based · BackgroundBackgroundMercaptopurineIntervention entry›As of now · Rule based · BackgroundBackgroundMethotrexateIntervention entry›As of now · Rule based · BackgroundBackgroundMethylprednisoloneIntervention entry›As of now · Rule based · TestedTestedPrednisoloneIntervention entry›As of now · Rule based · TestedTestedPrednisoneIntervention entry›As of now · Rule based · TestedTestedHydrocortisoneEntry “Therapeutic Hydrocortisone”, r…›As of now · Rule based · BackgroundBackgroundThioguanineIntervention entry›As of now · Rule based · BackgroundBackgroundVenetoclaxIntervention entry›As of now · Rule based · TestedTestedVincristineIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Leukemia, Biphenotypic, Acute

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryLeukemia, Biphenotypic, Acute, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Sep 25The record itselfClinicalTrials.gov recordVersion of 2026-09-25Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Oct 19The record itselfClinicalTrials.gov recordVersion of 2026-10-19Record change
Oct 20The record itselfClinicalTrials.gov recordVersion of 2026-10-20Record change
Oct 21The record itselfClinicalTrials.gov recordVersion of 2026-10-21Record change
Oct 27The record itselfClinicalTrials.gov recordVersion of 2026-10-27Record change
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
As of nowLeukemia, Biphenotypic, AcuteRule based · main-condition ruleMain conditionCurrent
As of nowAsparaginase erwinia chrysanthemiRule based · role ruleBackgroundCurrent
As of nowBlinatumomabRule based · role ruleTestedCurrent
As of nowCalaspargase pegolRule based · role ruleBackgroundCurrent
As of nowCyclophosphamideRule based · role ruleBackgroundCurrent
As of nowCytarabineRule based · role ruleBackgroundCurrent
As of nowDaunorubicinRule based · role ruleBackgroundCurrent
As of nowDexamethasoneRule based · role ruleBackgroundCurrent
As of nowDoxorubicinRule based · role ruleBackgroundCurrent
As of nowLeucovorinRule based · role ruleBackgroundCurrent
As of nowLevoleucovorinRule based · role ruleBackgroundCurrent
As of nowMercaptopurineRule based · role ruleBackgroundCurrent
As of nowMethotrexateRule based · role ruleBackgroundCurrent
As of nowMethylprednisoloneRule based · role ruleTestedCurrent
As of nowPrednisoloneRule based · role ruleTestedCurrent
As of nowPrednisoneRule based · role ruleTestedCurrent
As of nowHydrocortisoneRule based · role ruleBackgroundCurrent
As of nowThioguanineRule based · role ruleBackgroundCurrent
As of nowVenetoclaxRule based · role ruleTestedCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.